ERBB2 and breast cancer: Likewise, cyclin-dependent kinase 12 (CDK12), a cyclin-dependent kinase involved in DNA damage repair and coamplified with HER2 at chromosome 17, was reported to play a key role in driving tumorigenesis and inducing anti-HER2 therapy resistance in human BC [67].